• Who-we-are-banner

    News

Charles Russell Speechlys advises Apposite Capital on acquisition of i2a Diagnostics

Charles Russell Speechlys has advised healthcare investor Apposite Capital on the management buy in of microbiology company i2a Diagnostics.

Created in 1988, i2a is a leading provider of laboratory instruments, software and reagents for the clinical microbiology market in France. The company specialises in offering automated solutions across the value chain of the bacteriology clinical testing market, including Antibiotic Sensitivity Testing which identifies bacterial resistance to antibiotics.

Anne-Laure Meynier, Investment Director at Apposite Capital, who will join the Board of i2a said: “With 700,000 deaths worldwide annually, antimicrobial resistance is a global health priority and Apposite believes that more solutions will be needed to fight it. i2a sees significant opportunities in supporting labs and clinicians with best-in-class solutions to adjust therapy and transform data into actionable insights and we are delighted to be working with the i2a Founding team on this exciting new investment.”

Thibaut Caharel, Corporate Partner at Charles Russell Speechlys commented: “We were delighted to assist Anne-Laure and the Apposite team on this transaction. We wish both Apposite and i2a every success as they continue to execute their international growth strategy in this important domain of research and software-enabled Antimicrobial Susceptibility testing solutions.”

The Charles Russell Speechlys team, led by Corporate Partner Thibaut Caharel, included Guillaume Ferrand (Corporate), Kim Campion and Laure de Ganay (Employment), and Raphaël Bagdassarian and Elea Reyes (Tax).

Our thinking

  • Charles Russell Speechlys advises on the acquisition of Wycombe Wanderers Football Club

    Keir Gordon

    News

  • Charles Russell Speechlys advises long standing client AgDevCo on its equity investment in Agris

    Adrian Mayer

    News

  • The Guardian and City AM quote Ashwin Pillay on Anglo American rejecting a second takeover bid from BHP

    Ashwin Pillay

    In the Press

  • Charles Russell Speechlys advises CLA UK on the acquisition of Engine B

    Charlie Ring

    News

  • ESG due diligence in private company M&A

    Megan Gray

    Insights

  • A Guide to Arbitrability in International Arbitration

    Peter Smith

    Insights

  • DIFC Courts Release 2023 Annual Report

    Peter Smith

    Quick Reads

  • Takeover Panel consults on narrowing the scope of the Takeover Code

    Jodie Dennis

    Insights

  • James Broadhurst writes for the Financial Times’ Your Questions column on inheriting company shares

    James Broadhurst

    In the Press

  • Charles Russell Speechlys bolsters corporate and commercial offering with the appointment of Shirley Fu in Hong Kong

    Shirley Fu

    News

  • Charles Russell Speechlys advises Give Back Beauty Group in the acquisition of INCC Parfums

    Dimitri A. Sonier

    News

  • Planning and Life Sciences: the challenges and opportunities in the Golden Triangle

    Sophie Willis

    Quick Reads

  • Arbitration: Getting value for your money

    Daniel McDonagh

    Insights

  • France: Employment and Labour Law Comparative Guide

    Kim Campion

    Insights

  • Charles Russell Speechlys advises Countryside Partnerships on its joint venture with Abri to develop 1,500 homes in West Sussex

    Sarah Wigington

    News

  • Charles Russell Speechlys advises Europlasma in takeover bid of MG-Valdunes

    Dimitri A. Sonier

    News

  • London’s Knowledge Clusters: From Emerging to Maturing – Start Ups on the Global Stage?

    Lynsey Inglis

    Quick Reads

  • Charles Russell Speechlys boosts international private wealth offering with the arrival of Amira Shaker-Bortman

    Amira Shaker-Bortman

    News

  • Mark Howard writes for the Evening Standard on the blocked Telegraph takeover, the NSI Act and the Enterprise Act 2002

    Mark Howard

    In the Press

  • Charles Russell Speechlys grows its rankings in The Legal 500 EMEA directory

    Frédéric Jeannin

    News

Back to top